Institutional investors purchased a net $829.1 thousand shares of ORMP during the quarter ended November 2013. This may signal that the smart money is gaining interest in this company as the 8.87% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
AWM INVESTMENT CO., INC. Bought 790.0 Thousand shares of Oramed Pharmaceuticals In...